A Multicenter Equivalence Study of Oral Amoxicillin versus Injectable Penicillin in Children Aged 3 to 59 Months with Severe Pneumonia Amoxicillin Penicillin.

Slides:



Advertisements
Similar presentations
Pneumonia MICS3 Data Analysis and Report Writing.
Advertisements

Areas of Research Specific issues. Clinical Trials Phase I First use in humans of an experimental drug or treatment In a small group of healthy volunteers.
New England Journal of Medicine October 18;367: Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease Molly Moncrieff.
Aftercare Attendance Partially Moderated by History of Physical Abuse and Gender Louise F. Haynes 1 ; Amy E. Herrin 1 ; Rickey E. Carter 1 ; Sudie E. Back.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
12 June 2004Clinical algorithms in public health1 Seminar on “Intelligent data analysis and data mining – Application in medicine” Research on poisonings.
Community Management of Possible Serious Newborn Infections: Simplified Antibiotic Regimens Bina Valsangkar, MD, MPH Saving Newborn Lives/Save the Children.
{ ADVERSE DRUG REACTIONS To ensure patient, family/caregiver and home health personnel are instructed to identify adverse reactions to medications and.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Intravenous Maintenance Fluids Friedman JN, Beck CE, DeGroot J, Geary DF, Sklansky.
T e c h n i c a l S e m i n a r s Acute Respiratory Infections Sensivity & specificity Definition Pneumonia RecognitionRecognition Fast breathing AntibioticsFast.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Design and Analysis of Clinical Study 12. Randomized Clinical Trials Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Pneumonia Sapna Bamrah, MD CDC
Dr. Simon Benson GP Specialist Trainee. Introduction Diagnosis of pneumonia in children with wheeze is difficult Limited data exists regarding predictors.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Clinical Trials Hanyan Yang
Integrated Management of Childhood Illnesses (IMCI) Dr. Pushpa Raj Sharma DCH, DTCH, FCPS Professor of Child Health Institute of Medicine, Kathmandu, Nepal.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Nebulized Hypertonic Saline for Bronchiolitis Florin TA, Shaw KN, Kittick M, Yakscoe.
Module 6 Inactivated poliovirus vaccine AEFI monitoring Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2008.
Pneumonia diagnosis and treatment Prognosis for severe disease.
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
SERIOUS ADVERSE EVENTS REPORTING Elizabeth Dayag IRB Administrator Naval Medical Center Portsmouth.
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Immunoglobulin plus prednisolone in severe Kawaski disease (RAISE study) Steph Borg 22 November 2012 SCH Journal Club.
Sarah Struthers, MD March 19, 2015
IMPACT OF EDUCATIONAL INTERVENTION ON PRESCRIBING BEHAVIOUR AND COST OF THERAPY IN BRONCHIAL ASTHMA IN COLONY HOSPITALS OF DELHI Kotwani A, Gupta U, Suri.
Treatment for Adolescents With Depression Study (TADS)
Effects of an HIV/AIDS peer prevention intervention on sexual and injecting risk behaviors among injecting drug users (IDUs) and their risk partners in.
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group,
Randomized controlled trial to evaluate a focused communication intervention to reduce length of stay for critically ill children in a pediatric intensive.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
DRAFT SLIDES FOR NDA ADVISORY COMMITTEE PRESENATIONS.
ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.
Monthly Journal article review: Vimmi Kang PGY 2
Raymond F. Anton, MD for The COMBINE Study Research Group
Lecture 5 Objective 14. Describe the elements of design of experimental studies: clinical trials and community intervention trials. Discuss the advantages.
TREATMENT OF SERO-DISCORDANT COUPLES: IMPLICATIONS FOR YOUNG PEOPLE JJ KUMWENDA (FRCP-UK)
1 Exploring Alternative Antibiotic Treatment Regimens: Methodology and Implications Dr. Tabish Hazir MASCOT Study Group 2 nd ICIUM Conference 2004.
Effect of community-wide isoniazid preventive therapy on tuberculosis among South African gold miners “Thibelo TB” Aurum Health Research LSHTM JHU Gold.
Asthma Management and the Allergist: Better Outcomes at Lower Cost.
How To Design a Clinical Trial
TREATMENT OF SEVERE PNEUMONIA WITH ORAL ANTIBIOTICS Lozano JM, on behalf of the APPIS Trial Group. Department of Pediatrics and Clinical Epidemiology Unit,
Indiaclen Short course of Amoxicillin in treatment of Pneumonia (ISCAP) 3 versus 5 days amoxicillin for treatment of non-severe pneumonia in young children:
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Intermittent vs Continuous Pulse Oximetry McCulloh R, Koster M, Ralston S, et al.
1 EFFICACY OF SHORT COURSE AMOXICILLIN FOR NON-SEVERE PNEUMONIA IN CHILDREN (Hazir T*, Latif E*, Qazi S** AND MASCOT Study Group) *Children’s Hospital,
Integrated Management of Childhood Illnesses
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
1 Recent Advances in Provision of Primary Care in the Public Sector: Is 3 Days of Oral Antibiotic Therapy Enough for Treatment of Ambulatory Pneumonia?
COSTS STUDY OF SEVERE PNEUMONIA IN AN EQUIVALENCE TRIAL OF ORAL AMOXICILLIN VERSUS INJECTABLE PENICILLIN IN CHILDREN AGED 3 TO 59 MONTHS Patel AB, APPIS.
Three days vs five days oral cotrimoxazole therapy in non-severe pneumonia Kartasasmita C, Samir K. Saha * and Cotrimoxazole Study Group Indonesia and.
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
Post-discharge chemoprevention of malaria in transfused children; a randomized trial in Uganda & Kenya R Idro, R Opoka, A Dhabangi, F TerKuile, and K Phiri.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
Antibiotics In Respiratory Infection To Use or Not to Use - that is the question. Dr. James Paton University of Glasgow.
PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16.
Journal Club Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy. Rebecca Luke 2/9/2016.
Antibiotics in Addition to Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease Johannes M.A. Daniels; Dominic snijders;
How To Design a Clinical Trial
Acute respiratory infections (ARI)
Bozeman Health Clinical Research
International Conference on Improving Use of Medicines
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
MANAGEMENT OF PCP Dr. Akaninyene A. Otu, MBBCh, DTM&H, MPH, MRCP (UK), FWACP University of Calabar Teaching Hospital Calabar, Nigeria.
LATIN-AMERICAN MULTICENTRE STUDY ON ANTIBIOTIC RESISTANCE OF S
Dr Immaculate Kariuki Consultant Paediatrician Nairobi, Kenya
Clinical Trials Oct. 6, Lyon France
Presentation transcript:

A Multicenter Equivalence Study of Oral Amoxicillin versus Injectable Penicillin in Children Aged 3 to 59 Months with Severe Pneumonia Amoxicillin Penicillin Pneumonia International Study (APPIS) Group Colombia, Ghana, India, Mexico, Pakistan, South Africa, Vietnam, Zambia Center for International Health, SPH, Boston University Department of Child and Adolescent Health & Development, WHO

2 Background Estimated 2.1 million ARI deaths in children every yearEstimated 2.1 million ARI deaths in children every year WHO-defined severe pneumonia: admission & treatment with injectable penicillin / ampicillinWHO-defined severe pneumonia: admission & treatment with injectable penicillin / ampicillin Drawbacks of hospitalization and injectable therapy:Drawbacks of hospitalization and injectable therapy: –Side effects: local and needle-borne infections –Costs: dispensing drugs, hospitalization Amoxicillin Penicillin Pneumonia International Study (APPIS)

3 Research Questions Primary: Is treatment failure at 48 h among children aged 3-59 months with WHO- defined severe pneumonia treated with oral amoxicillin equivalent to that with injectable penicillinPrimary: Is treatment failure at 48 h among children aged 3-59 months with WHO- defined severe pneumonia treated with oral amoxicillin equivalent to that with injectable penicillin? Secondary: Do the two treatments remain clinically equivalent through follow-up on days 5 and 14?Secondary: Do the two treatments remain clinically equivalent through follow-up on days 5 and 14? Amoxicillin Penicillin Pneumonia International Study (APPIS)

4 Study design and setting Non-blinded, equivalency randomized clinical trialNon-blinded, equivalency randomized clinical trial Nine tertiary care centers in eight low & middle income countries in three continents:Nine tertiary care centers in eight low & middle income countries in three continents: -Colombia -Ghana -India -Mexico -Pakistan (2 sites) -South Africa -Vietnam -Zambia Amoxicillin Penicillin Pneumonia International Study (APPIS)

5 Inclusion Criteria  Children aged 3 to 59 months with WHO-defined severe pneumonia (lower chest indrawing in children with cough and/or difficult breathing) WHO-defined severe pneumonia (lower chest indrawing in children with cough and/or difficult breathing)  Informed consent by a legal guardian Amoxicillin Penicillin Pneumonia International Study (APPIS)

6 Exclusion Criteria Very severe disease (severe malnutrition)Very severe disease (severe malnutrition) Chronic or congenital conditionsChronic or congenital conditions Antibiotics for more than 48 hrsAntibiotics for more than 48 hrs Hospitalization in prior two weeksHospitalization in prior two weeks Bronchial asthma or wheeze whose LCI improved with inhaled salbutamolBronchial asthma or wheeze whose LCI improved with inhaled salbutamol Measles in the last one monthMeasles in the last one month Oxygen saturation < 80%/75% in room airOxygen saturation < 80%/75% in room air Clinical evidence of HIV infection (clinical category B or C, CDC-defined)Clinical evidence of HIV infection (clinical category B or C, CDC-defined) Known penicillin allergyKnown penicillin allergy Previous inclusion in studyPrevious inclusion in study Living outside study areaLiving outside study area Amoxicillin Penicillin Pneumonia International Study (APPIS)

7 Trial Entry and Interventions Clinical baseline and naso - pharyngeal sampling for RSV and routine microbiologyClinical baseline and naso - pharyngeal sampling for RSV and routine microbiology Randomization:Randomization: –Computer generated at coordinating center (WHO) –Opaque, sealed and numbered envelopes Interventions:Interventions: –Injectable penicillin G 200,000 IU/kg/day in four doses –Oral amoxicillin 45 mg/kg/day in three doses Amoxicillin Penicillin Pneumonia International Study (APPIS)

8 Follow up In hospital: every 6 h for at least 48 hIn hospital: every 6 h for at least 48 h Outpatient clinic: 5 and 14 daysOutpatient clinic: 5 and 14 days Data collected by trained observers:Data collected by trained observers: –Vital signs –Presence of danger signs –Lower chest indrawing –Oxygen saturation by pulse oximetry –Adverse events Amoxicillin Penicillin Pneumonia International Study (APPIS)

9 Outcomes Primary: failure at 48 hours:Primary: failure at 48 hours: –Persistence of severe pneumonia (LCI) –Danger signs (very severe disease) –Death –Severe hypoxemia (< 80%/75%) –Life-threatening or serious adverse drug reaction –Received another antibiotic –Newly diagnosed condition –Voluntary withdrawal Secondary: failure at 5 and 14 days:Secondary: failure at 5 and 14 days: –As for failure at 48 h –Recurrence of LCI or hypoxemia (<90%/88%) –Non-severe pneumonia on day 14 Amoxicillin Penicillin Pneumonia International Study (APPIS)

10 Sample size and analysis Sample size: Equivalence trial:Sample size: Equivalence trial: –Expected failure rate with penicillin: 10% –Equivalence: rate amoxicillin = penicillin  5% –Alpha 0.05 (one side), power 90% –Loss to follow-up at 48 h: 1% –Three interim and one final analyses –861 children per group (1,722) Analysis:Analysis: –Failure rates difference and 95%CI –Intention to treat and per protocol analysis Amoxicillin Penicillin Pneumonia International Study (APPIS)

11 Ethical issues Review and approval by the Institutional Review Board in all participating and coordinating centersReview and approval by the Institutional Review Board in all participating and coordinating centers Monitoring by an independent Data Safety Monitoring Board three times along the studyMonitoring by an independent Data Safety Monitoring Board three times along the study Second interim analysis: trend to increased early deaths at sites with high prevalence of HIV = exclusion of children under one year with oral thrush, hepatosplenomegaly or parent known to be HIV-infectedSecond interim analysis: trend to increased early deaths at sites with high prevalence of HIV = exclusion of children under one year with oral thrush, hepatosplenomegaly or parent known to be HIV-infected Amoxicillin Penicillin Pneumonia International Study (APPIS)

12 Baseline comparison Amoxicillin Penicillin Pneumonia International Study (APPIS)

13 Study profile

14 Treatment failures Amoxicillin Penicillin Pneumonia International Study (APPIS)

15 Reasons for failure at 48 hours Amoxicillin Penicillin Pneumonia International Study (APPIS)

16 Baseline risk factors for failure at 48 h Amoxicillin Penicillin Pneumonia International Study (APPIS)

17 Cost-minimization Study Conducted at Indira Gandhi Medical College, Nagpur, India (Dr. A. Patel)Conducted at Indira Gandhi Medical College, Nagpur, India (Dr. A. Patel) Amoxicillin therapy is associated with significant reductions in:Amoxicillin therapy is associated with significant reductions in: –Medication costs –Direct medical costs –Total costs Amoxicillin Penicillin Pneumonia International Study (APPIS)

18 Discussion Main finding: oral amoxicillin and injectable penicillin are equally effective in terms of treatment failures and clinical relapse ratesMain finding: oral amoxicillin and injectable penicillin are equally effective in terms of treatment failures and clinical relapse rates Treatment failure rates higher than expected:Treatment failure rates higher than expected: –Strict but non validated criteria –High incidence of wheeze associated with lower chest indrawing at 48 h –HIV – infected children with newly diagnosed conditions –Hypoxemia associated with high altitude Clinical efficacy of amoxicillin and penicillin is equivalent to other more expensive antibioticsClinical efficacy of amoxicillin and penicillin is equivalent to other more expensive antibiotics Amoxicillin Penicillin Pneumonia International Study (APPIS)

19 Conclusions Oral amoxicillin and injectable penicillin are equally effective in hospitalized children with severe pneumoniaOral amoxicillin and injectable penicillin are equally effective in hospitalized children with severe pneumonia Use of oral amoxicillin reduces the costs associated with treatmentUse of oral amoxicillin reduces the costs associated with treatment Caution is needed for using these findings in high HIV prevalence areasCaution is needed for using these findings in high HIV prevalence areas Amoxicillin Penicillin Pneumonia International Study (APPIS)

20 Acknowledgements Participating children and their parentsParticipating children and their parents Sponsors:Sponsors: –Department of Child and Adolescent Health & Development, WHO –ARCH Project Data Safety Monitoring Board membersData Safety Monitoring Board members Staff at research centersStaff at research centers Amoxicillin Penicillin Pneumonia International Study (APPIS)

A Multicenter Equivalence Study of Oral Amoxicillin versus Injectable Penicillin in Children Aged 3 to 59 Months with Severe Pneumonia Amoxicillin Penicillin Pneumonia International Study (APPIS) Group Colombia, Ghana, India, Mexico, Pakistan, South Africa, Vietnam, Zambia Center for International Health, SPH, Boston University Department of Child and Adolescent Health & Development, WHO

23 Some Potential Policy Implications Practical benefits of switching-over to oral amoxicillin:Practical benefits of switching-over to oral amoxicillin: –Simpler treatment –Reduction in direct costs –Health workers can start therapy at primary facilities –Treatment option for severe pneumonia when referral is not feasible / desirable Amoxicillin Penicillin Pneumonia International Study (APPIS)

24 Some Limitations of Data for Policy RCT conducted in controlled environment (close monitoring)RCT conducted in controlled environment (close monitoring) Safety of treating severe pneumonia in communities is unknownSafety of treating severe pneumonia in communities is unknown Children with severe pneumonia are admitted to hospital due to several reasons:Children with severe pneumonia are admitted to hospital due to several reasons: –Administration of injectable antibiotics –Identification and treatment of associated hypoxemia –Ensuring compliance with treatment –Need for additional observation  APPIS data do not address home treatment of severe pneumonia Amoxicillin Penicillin Pneumonia International Study (APPIS)

25 How to move on? Further analysis of APPIS data:Further analysis of APPIS data: –Features that predict severe hypoxemia –Relationship between hypoxemia and therapy failure –Further look of children screened but excluded Need to collect information from hospitals in LMIC about:Need to collect information from hospitals in LMIC about: –Availability of oxygen for treating severe pneumonia –Current prevalent practices for oxygen administration Home vs. hospital treatment of severe pneumonia:Home vs. hospital treatment of severe pneumonia: –RCT of outpatient management of severe pneumonia –Carefully conducted descriptive studies Amoxicillin Penicillin Pneumonia International Study (APPIS)